News
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” second-quarter 2025 investor letter ...
Vanderpump Rules' star Scheana Shay is reacting to Peter Madrigal saying that he doesn't like the former members of the show.
Defining workplace culture, elevating customer service and strengthening collaboration have been the name of the game for ...
Madrigal Pharmaceuticals, Inc.'s Rezdiffra saw Q2 net sales soar 55% to $212.8M amid strong growth. EU approval expected by ...
5d
Pharmaceutical Technology on MSNMadrigal wins European MASH approval as Novo rivalry looms
Madrigal Pharmaceuticals’ Rezdiffra has been approved in Europe for the treatment of MASH with moderate to advanced liver ...
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it ...
The FDA clearance sets Novo’s medicine up for a market battle with Madrigal Pharmaceuticals’ fast-selling Rezdiffra.
Yet the topline results released by Madrigal Pharmaceuticals MDGL 0.70% on Monday looked better than most analysts had expected, sending the stock soaring 220%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results